Fresenius Medical Care AG (0H9X.IL)

39,40 -0,85 (-2,11 %) À partir de 03:31PM BST. Marché ouvert.

Fresenius Medical Care AG

Else-KrOener-Strasse 1
Bad Homburg 61352
Germany
49 6172 609 0
https://www.freseniusmedicalcare.com

Secteur(s): Healthcare
Secteur d’activité: Medical Care Facilities
Employés à temps plein: 124 295

Dirigeants clés

Nom	Titre	Payer	Exercé	Année de naissance
Ms. Helen Giza	CEO & Chair of Management Board of Fresenius Med. Care Mgmt AG	3,21M	S.O.	1968
Dr. Franklin W. Maddux F.A.C.P.	Global Chief Medical Officer & Member of Management Board of Fresenius Medical Care Management AG	2,42M	S.O.	1957
Mr. William J. Valle	Management Board Member for Care Delivery of Fresenius Medical Care Management AG	3,93M	S.O.	1960
Dr. Katarzyna Mazur-Hofsab Ph.D.	Management Board Member for Care Enablement of Fresenius Medical Care Management AG	2,35M	S.O.	1963
Mr. Roberto Fuste	Exec. Advisor for Regional Strategy	S.O.	S.O.	1952
Mr. Martin Fischer	CFO & Member of the Management Board of Fresenius Medical Care Management AG	S.O.	S.O.	1977
Dr. Dominik Heger	Exec. VP and Head of Investor Relations, Strategic Devel. & Communications	S.O.	S.O.	S.O.
Mr. Borries Von Muller	Sr. VP of Global HR Employee Communications	S.O.	S.O.	1961
Mr. Joachim Weith	Sr. VP of Corp. Communications & Gov.al Affairs	S.O.	S.O.	S.O.
Mr. Oliver Maier	Sr. VP Investor Relations	S.O.	S.O.	S.O.

Les montants ont été établis en date du 31 décembre 2022 et les valeurs de compensation concernent le dernier exercice fiscal clos à cette date. Le terme « rémunération » désigne le salaire, les bonus, etc. Le terme « exercé » est utilisé pour la valeur des options exercées au cours de l’exercice fiscal. Devise exprimée en EUR.

Description

Fresenius Medical Care AG & Co. KGaA provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. It also develops, manufactures, and distributes various health care products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, systems for water treatment, and acute cardiopulmonary and apheresis products. In addition, the company develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, vascular care ambulatory surgery center, and physician nephrology and cardiology services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. Fresenius Medical Care AG & Co. KGaA was incorporated in 1996 and is headquartered in Bad Homburg, Germany.

Gouvernance d’entreprise

L’ISS Governance QualityScore de Fresenius Medical Care AG en date du 1 octobre 2023 est 8. Les scores principaux sont Audit : 2; Société : 6; Droits des actionnaires : 1; Compensation : 9.

Résultats de gouvernance d’entreprise offerts par Institutional Shareholder Services (ISS). Les résultats indiquent un rang décile par rapport à l’indice ou à la région. Un résultat décile de 1 indique un risque de gouvernance faible, tandis que 10 indique un risque de gouvernance élevé.